Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VRSUSD

(VRSUSD)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/13/20242:48AMAlliance NewsAlliance NewsLONDON BRIEFING: Diploma upgrades annual guidance amid good momentum
05/13/20242:46AMGlobeNewswire Inc.TRANSFORMA ANNOUNCES FAILURE TO FILE CEASE TRADE ORDERTSXV:TFMTransforma Resources Corporation
05/13/20242:46AMPR Newswire (US)Dental Polishing Machine Market to Reach $6.5 Billion Globally by 2032 at 6.1% CAGR: Allied Market Research
05/13/20242:45AMGlobeNewswire Inc.Yara International and Kongsberg Digital enter collaboration on digital twin technologyTG:IU2Yara International ASA.
05/13/20242:33AMBusiness WireUnited Fintech expands global presence into UAE with new office in DIFC
05/13/20242:33AMBusiness WireIntroducing ScoliCare® Clinic East Phoenix
05/13/20242:30AMGlobeNewswire Inc.Preliminary data on early redemptions (prepayments)
05/13/20242:30AMGlobeNewswire Inc.Inventiva annonce la publication dans Nature Communications de résultats complémentaires de l’étude clinique de Phase II NATIVE démontrant l’amélioration de marqueurs de santé cardiométabolique chez les patients atteints de MASH/NASH traitéEU:IVAInventiva
05/13/20242:30AMGlobeNewswire Inc.GOGL – Invitation to presentation of Q1 2024 ResultsNASDAQ:GOGLGolden Ocean Group Limited
05/13/20242:30AMGlobeNewswire Inc.Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranorTG:6IVInventiva
05/13/20242:30AMGlobeNewswire Inc.Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranorLSE:0RNKInventiva Sa
05/13/20242:30AMGlobeNewswire Inc.Inventiva annonce la publication dans Nature Communications de résultats complémentaires de l’étude clinique de Phase II NATIVE démontrant l’amélioration de marqueurs de santé cardiométabolique chez les patients atteints de MASH/NASH traitéTG:6IVInventiva
05/13/20242:30AMBusiness WireYara Clean Ammonia and AM Green (Earlier Greenko ZeroC) Sign Term Sheet for Sale of Renewable Ammonia From India to Yara Clean Ammonia’s Global Market
05/13/20242:30AMGlobeNewswire Inc.GOGL – Invitation to presentation of Q1 2024 ResultsTG:KT31Golden Ocean Group Limited
05/13/20242:30AMGlobeNewswire Inc.Inventiva annonce la publication dans Nature Communications de résultats complémentaires de l’étude clinique de Phase II NATIVE démontrant l’amélioration de marqueurs de santé cardiométabolique chez les patients atteints de MASH/NASH traitéLSE:0RNKInventiva Sa
05/13/20242:30AMGlobeNewswire Inc.Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranorEU:IVAInventiva
05/13/20242:30AMGlobeNewswire Inc.Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranorEU:IVAInventiva
05/13/20242:30AMGlobeNewswire Inc.Coop Pank AS application for obtaining an additional license for issuing covered bonds
05/13/20242:27AMPR Newswire (US)Autoliv Announces Results of 2024 Annual General Meeting of StockholdersNYSE:ALVAutoliv Inc
05/13/20242:13AMGlobeNewswire Inc.Tap offering of UAB „Atsinaujinančios energetikos investicijos“ bonds under the EUR 100 million Green Bonds Programme
05/13/20242:13AMPR Newswire (US)Autoliv Announces Results of 2024 Annual General Meeting of StockholdersNYSE:ALVAutoliv Inc
05/13/20242:10AMGlobeNewswire Inc.Exor Press Release - Periodic Report on the Buyback ProgramBIT:EXOExor NV
05/13/20242:10AMGlobeNewswire Inc.Exor Press Release - Periodic Report on the Buyback ProgramTG:EYXExor NV
05/13/20242:10AMGlobeNewswire Inc.Exor Press Release - Periodic Report on the Buyback ProgramXE:EYXExor NV
05/13/20242:10AMGlobeNewswire Inc.Exor Press Release - Periodic Report on the Buyback ProgramEU:EXOExor NV
05/13/20242:02AMPR Newswire (Canada)Alvopetro Announces Results of Emergency ArbitrationTSXV:ALVAlvopetro Energy Ltd
05/13/20242:01AMBusiness WirePSNC and ORCA Computing Announce Collaboration with NVIDIA to Accelerate the Development of Hybrid Quantum Classical High-Performance Computing
05/13/20242:00AMGlobeNewswire Inc.QIAGEN erhält FDA-Zulassung für syndromischen QIAstat-Dx-Test zur schnellen und präzisen Diagnose von AtemwegserkrankungenXE:QIAQiagen NV
05/13/20242:00AMGlobeNewswire Inc.Groupe Casino : Cession de GreenYellowEU:COCasino Guichard Perrachon
05/13/20242:00AMBusiness WirePatron Capital Raises in Excess of €860 Million ($920 Million) for Fund VII

Your Recent History

Delayed Upgrade Clock